Description: Ubrelvy 100 mg Tablets are a prescription medication used to treat acute migraine attacks in adults. The active ingredient, ubrogepant, is a calcitonin gene-related peptide (CGRP) receptor antagonist that works by blocking the action of CGRP, a substance involved in the development of migraine headaches. Ubrelvy is designed to provide relief from the symptoms of migraine, including pain, nausea, and sensitivity to light and sound.
Ingredients:
- Active Ingredient: Ubrogepant 100 mg
- Other Ingredients: [List any inactive ingredients if known]
Usage Instructions:
- Dosage: Take one 100 mg tablet orally as soon as possible after the onset of a migraine.
- Frequency: A second dose may be taken after 2 hours if the migraine returns, but do not exceed 200 mg in a 24-hour period.
- Special Considerations: Do not use Ubrelvy for the prevention of migraines. It is intended for the acute treatment of migraine attacks only. Follow your healthcare provider's instructions for optimal use.
Benefits:
- Provides effective relief from acute migraine attacks.
- Works by targeting and blocking CGRP, a key player in migraine pathophysiology.
- Can be taken with or without food.
- Allows for flexible dosing, with the option of a second dose if needed.
Precautions:
- Contraindications: Not recommended for individuals with known hypersensitivity to ubrogepant or any other components of the tablet.
- Side Effects: Possible side effects include nausea, fatigue, dry mouth, and dizziness. Serious side effects may include allergic reactions or liver problems. Seek medical attention if severe symptoms occur.
- Consult with your doctor if you have liver disease or are taking other medications, as dosage adjustments may be necessary.
Storage Instructions:
- Store at room temperature (15-30°C).
- Keep in a dry place away from moisture and direct sunlight.
- Keep the tablets in their original packaging until use.
- Keep out of reach of children.
Manufacturer:
